Myostatin blockade improves function but not histopathology in a murine model of limb‐girdle muscular dystrophy 2C

S Bogdanovich, EM McNally… - Muscle & Nerve: Official …, 2008 - Wiley Online Library
Myostatin is a negative regulator of skeletal muscle growth. Myostatin mutations and
pharmacological strategies increase muscle mass in vivo, suggesting that myostatin …
被引用次数：116 相关文章

[引用][C] MYOSTATIN BLOCKADE IMPROVES FUNCTION BUT NOT HISTOPATHOLOGY IN A MURINE MODEL OF LIMB-GIRDLE MUSCULAR DYSTROPHY 2C

S BOGDANOVICH, EM MCNALLY… - Muscle & …, 2008 - pascal-francis.inist.fr
MYOSTATIN BLOCKADE IMPROVES FUNCTION BUT NOT HISTOPATHOLOGY IN A MURINE
MODEL OF LIMB-GIRDLE MUSCULAR DYSTROPHY 2C CNRS Inist Pascal-Francis CNRS …

Myostatin blockade improves function but not histopathology in a murine model of limb-girdle muscular dystrophy 2C

S Bogdanovich, EM McNally… - Muscle and …, 2008 - scholars.northwestern.edu
Myostatin is a negative regulator of skeletal muscle growth. Myostatin mutations and
pharmacological strategies increase muscle mass in vivo, suggesting that myostatin …

Myostatin blockade improves function but not histopathology in a murine model of limb-girdle muscular dystrophy 2C.

S Bogdanovich, EM McNally, TS Khurana - Muscle & Nerve, 2008 - europepmc.org
Myostatin is a negative regulator of skeletal muscle growth. Myostatin mutations and
pharmacological strategies increase muscle mass in vivo, suggesting that myostatin …

Myostatin blockade improves function but not histopathology in a murine model of limb-girdle muscular dystrophy 2C

S Bogdanovich, EM McNally… - Muscle & nerve, 2008 - pubmed.ncbi.nlm.nih.gov
Myostatin is a negative regulator of skeletal muscle growth. Myostatin mutations and
pharmacological strategies increase muscle mass in vivo, suggesting that myostatin …

[引用][C] MYOSTATIN BLOCKADE IMPROVES FUNCTION BUT NOT HISTOPATHOLOGY IN A MURINE MODEL OF LIMB-GIRDLE MUSCULAR DYSTROPHY 2C

S BOGDANOVICH, EM MCNALLY, TS KHURANA MD - Muscle & nerve, 2008 - Wiley